Pharmacovigilance E-Shots

Date Safety Update
3-Oct-2019 Recall of Sure Lubricated Condoms Dotted
2-Oct-2019 Genotoxic contaminant, N-nitrosodimethylamine (N-NDMA) Impurity, in Ranitidine products
14-Mar-2019 Press Statement: Fluoroquinole Antibiotics, Hydrochlorthiazide Products and Valsartan Containing Products
14-Jan-2019 Hydrochlorothiazide (HCTZ) Risk of Non-Melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)
14-Jan-2019 Systemic and inhaled quinolone and fluoroquinolone antibiotics
12-Jul-2018 Recall of Valsartan containing products by Denk Pharma
11-Jul-2018 Recall of some specific brands of Gentamicin injection in the Kenyan market
11-Jul-2018 Recall of specific batches of Folfes tablets, Hexon 5% disinfectant and Ventil tablets from Biodeal Laboratories Ltd
9-May-2018 Alert on Falsified Postinor-2
8-May-2018 Important identified signals on Artemether Lumefantrine
8-May-2018 Important identified signals on Ceftriaxone
8-May-2018 Alert on falsified Primaquine
26-Mar-2018 Recall of Gentamed injection batch no. 170603
8-Aug-2013 Suspension of registration of Hydroethyl Starch (HES) containing solutions
19-Mar-2010 Increased risk of myopathy with high doses of Simvastatin
23-Feb-2010 Prolongation of the QT interval due to Saquinavir boosted with Ritonavir 
29-Jan-2010 Risk of non-cirrhotic portal hypertension in patients using Didanosine
21-Jul-2009 Public Alert on Herbal Contraceptive
21-Apr-2009 Updated recommendations concerning the interaction of Ceftriaxone and Calcium containing products